Eli Lilly and Company (NYSE: LLY) Thursday reported a sharp increase in its fourth-quarter revenues. The pharmaceutical company’s adjusted earnings more than doubled during the quarter.
![](data:image/svg+xml;charset=utf-8,<svg height="2021px" width="1280px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
Worldwide revenue increased 45% year-over-year to $13.53 billion in the December quarter, reflecting strong sales growth across the main operating segments.
Fourth-quarter adjusted earnings climbed to $5.32 per share from $2.49 per share in the corresponding quarter a year earlier. Net income, on an unadjusted basis, rose sharply to $4.41 billion or $4.88 per share in Q4 from $2.19 billion or $2.42 per share in the prior year period.
![](data:image/svg+xml;charset=utf-8,<svg height="2560px" width="1621px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
